Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo
✍ Scribed by Liang Zhang; Zhengzi Qian; Zhen Cai; Luhong Sun; Huaqing Wang; J. Blake Bartlett; Qing Yi; Michael Wang
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 805 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract 2‐methoxyestradiol (2ME~2~) is an endogenous metabolite of estradiol with estrogen‐receptor‐independent antitumor and antiangiogenic activity. We examined the effects of 2ME~2~ on the cellular proliferation of 8 human melanoma cell lines. We show that 2ME~2~ inhibited cell proliferation
## Abstract __cis__‐Dichlorodiammineplatinum and 5‐aza‐2′‐deoxycytidine display a considerable synergistic effect in L1210 and La mouse leukemia __in vivo__; the combination of both drugs is also clearly synergistic __in vitro__as evidenced by the effects on cell growth and cell survival in soft‐ag
## Abstract The present study demonstrates that LICC possess both __in vitro__ and __in vivo__ antitumor activity. The LICC were generated by culturing normal spleen cells with syngeneic peritoneal cells and indomethacin, or with a conditioned medium containing IL 2 with or without a putative new l
The synergistic antitumor activity of mitomycin C (MMC) and cisplatin (DDP) against the gastric cancer cell lines MKN-28 and MKN-45 was assessed in vitro using the MTT assay. The synergism of the two agents was evaluated in terms of the interaction index (1.1.). The sequence of MMC followed by DDP s